Table 1. Patient and subject... | American Society of Hematology

Table 1.

Patient and subject characteristics

Patients/subjects and diagnoses		n	Male/female (n)	Age, y (quartiles)	CD4 cell count, cells/mm³ (quartiles)	HHV-8 DNA, log₁₀ copies/10⁶ cells (quartiles)	HIV RNA, log₁₀ copies/mL (quartiles)
MCD patients	HIV⁻ MCD	8	7/1	68.5 (61-84)*	562 (405-2117)	5 (2.5-5.75)	NR
MCD patients	HIV⁺ MCD	24	19/5	45.5 (33.5-51)	307 (130-500)†	5.7 (3.75-6.48)	1.44 (<1.3-2.75)
KS patients	HIV⁻ KS	11	10/1	62 (57-73)*	576 (416-906.3)	<2	NR
KS patients	HIV⁺ KS	13	11/2	40 (35.5-49)	337 (120-449)†	<2	2.045 (<1.6-4.8)
HDs	—	29	14/15	28 (25-41)	—	NR	NR

Patients/subjects and diagnoses		n	Male/female (n)	Age, y (quartiles)	CD4 cell count, cells/mm³ (quartiles)	HHV-8 DNA, log₁₀ copies/10⁶ cells (quartiles)	HIV RNA, log₁₀ copies/mL (quartiles)
MCD patients	HIV⁻ MCD	8	7/1	68.5 (61-84)*	562 (405-2117)	5 (2.5-5.75)	NR
MCD patients	HIV⁺ MCD	24	19/5	45.5 (33.5-51)	307 (130-500)†	5.7 (3.75-6.48)	1.44 (<1.3-2.75)
KS patients	HIV⁻ KS	11	10/1	62 (57-73)*	576 (416-906.3)	<2	NR
KS patients	HIV⁺ KS	13	11/2	40 (35.5-49)	337 (120-449)†	<2	2.045 (<1.6-4.8)
HDs	—	29	14/15	28 (25-41)	—	NR	NR

Data are median (quartiles) values. No significant differences were found for ages between patients HIV⁻ with MCD and with KS and for CD4 T-cell counts between patients HIV⁺ with MCD and with KS. Significant P < .05, Mann-Whitney test.

NR, not relevant.

P = .26.

†

P = .9.

View Large

This Feature Is Available To Subscribers Only